Central Illustration.

Pre-Existing HF and Outcomes in Older Patients With Hodgkin Lymphoma

Cumulative incidence of lymphoma mortality (blue), cardiovascular mortality (red), and all-cause mortality (black) stratified by the presence or absence of pre-existing heart failure (HF). The dashed line represents patients with HF at the time of lymphoma diagnosis, and solid lines represent patient without HF at the time of lymphoma diagnosis. In addition to the cause-specific mortality results, the figure also summarizes the other key findings of the study, including the prevalence of pre-existing HF, associations with anthracycline treatment, and low use of the cardioprotective agents dexrazoxane and liposomal doxorubicin. SEER = Surveillance, Epidemiology, and End Results.